Connect with us
Psychedelic clinical research firm Alira Health will collaborate with the Scottsdale Research Institute (SRI) to provide regulatory and clinical support to bring clinical research of psilocybin...
The sale retired about $44.5 million in debt for Blüm. Blüm Holdings Inc. (OTCQB: BLMH) has taken a major step in its bid to restructure its finances,...
Relmada Therapeutics Inc. (Nasdaq: RLMD) announced the publication of “promising” REL-1017 clinical data from the Reliance I Study in the peer-reviewed journal, The Journal of Clinical...
This story was republished with permission from Crain’s Cleveland Business and written by Jeremy Nobile. Klutch Cannabis fought the law and won — more or less....
The Canadian cannabis industry has suffered several waves of insolvencies and restructurings, but one of the industry’s biggest winners is plotting an ambitious yet prudent expansion...
Alisha Holloway has been deep in the world of cannabis genetics research for nearly a decade. With a strong background in genetics, Holloway has spent most...
The free-wheeling days of New York’s unlicensed cannabis market are numbered. At least, that’s the message from Gov. Kathy Hochul, New York City Mayor Eric Adams,...
News from: Blüm Holdings, New York, RAW, California State Fair, and more. The Daily Hit is a recap of the top financial news stories for Tuesday,...
The California State Fair in Sacramento is poised to become the first such institution to allow marijuana sales and consumption when the fair convenes on July...
Despite recent media focus on various U.S. cannabis markets being in decline and lamentations of marijuana business failures galore, San Diego-based Adam Stettner, the CEO of...
